India Anticoagulation Therapy Market to 2032
Overview
The India Anticoagulation Therapy Market is expected to reach a 3,456.64 USD Billion by 2032 and is projected to grow at a CAGR of 11.88% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1,719.81
Forecast, 2032 (USD Billion)
3,456.64
CAGR, 2024 - 2032
11.88%
Report Coverage
India
India Anticoagulation Therapy Market 2018-2032 USD Billion
India Anticoagulation Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1,719.81 USD Billion
- Projected Market Size (2032): 3,456.64 USD Billion
- CAGR (2025-2032): 11.88%
Key Findings of India Anticoagulation Therapy Market
- The India Anticoagulation Therapy Market was valued at 1,719.81 USD Billion in 2024.
- The India Anticoagulation Therapy Market is likely to grow at a CAGR of 11.88% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Generics in Type Segment accounted for the largest share of the market with a revenue of 1,135.39 USD Billion
- The fastest growing segment Apixaban in Drug Type Segment grew Fastest with a CAGR of 13.46% during the forecast period from 2024 to 2032.
India Anticoagulation Therapy Market Scope
India Anticoagulation Therapy Market Segmentation & Scope
Route of Administration
- Injectable
- Oral
Therapeutic Area
- Others
- CNS
- Respiratory
- Nephrology
- Oncology
- Cardiovascular Diseases
Procedure
- Heart Valve Replacement
- Kidney Dialysis
- Post-Surgical Procedures
- Pre-Surgical Procedures
Type
- Branded
- Generics
Therapeutic Class
- Others
- Vitamin K Antagonists
- Heparin
- Novel Oral Anticoagulants (NOAC)
Drug Type
- Delteparin
- Betrixaban
- Edoxaban
- Others
- Bivalirudin
- Dabigatran
- Enoxaparin
- Rivaroxaban
- Apixaban
End User
- Others
- Ambulatory Surgical Centers
- Homecare
- Clinics
- Hospitals
Distribution Channel
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
Treatment
- Others
- Stroke
- Arterial Thromboembolism(AT)
- Pulmonary Embolism(PE)
- Deep Vein Thrombosis (DVT)
India Anticoagulation Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1,719.81 USD Billion |
| Market Value in 2032 | 3,456.64 USD Billion |
| CAGR (2025-2032) | 11.88% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Route of Administration,Therapeutic Area,Procedure,Type,Therapeutic Class,Drug Type,End User,Distribution Channel,Treatment |
Regional Insights:
-
Leading Market (2024-2032): India, leading in terms of revenue 1,719.81 USD Billion in 2024
- Key Country: India, leading in terms of revenue with value of 1,719.81 USD Billion in 2024.
Segments and Scope
-
India Anticoagulation Therapy Market to 2032, By Route of Administration
- Oral is the largest segment in India Anticoagulation Therapy Market to 2032 with a revenue of 1,032.24 USD Billion in the year 2024.
- Oral is the Fastest growing segment in India Anticoagulation Therapy Market to 2032 with a Growth rate of 12.36 % in forecast period 2025-2032.
-
India Anticoagulation Therapy Market to 2032, By Therapeutic Area
- Cardiovascular Diseases is the largest segment in India Anticoagulation Therapy Market to 2032 with a revenue of 704.87 USD Billion in the year 2024.
- Cardiovascular Diseases is the Fastest growing segment in India Anticoagulation Therapy Market to 2032 with a Growth rate of 12.80 % in forecast period 2025-2032.
-
India Anticoagulation Therapy Market to 2032, By Procedure
- Pre-Surgical Procedures is the largest segment in India Anticoagulation Therapy Market to 2032 with a revenue of 1,006.27 USD Billion in the year 2024.
- Pre-Surgical Procedures is the Fastest growing segment in India Anticoagulation Therapy Market to 2032 with a Growth rate of 12.81 % in forecast period 2025-2032.
-
India Anticoagulation Therapy Market to 2032, By Type
- Generics is the largest segment in India Anticoagulation Therapy Market to 2032 with a revenue of 1,135.39 USD Billion in the year 2024.
- Generics is the Fastest growing segment in India Anticoagulation Therapy Market to 2032 with a Growth rate of 12.10 % in forecast period 2025-2032.
-
India Anticoagulation Therapy Market to 2032, By Therapeutic Class
- Novel Oral Anticoagulants (NOAC) is the largest segment in India Anticoagulation Therapy Market to 2032 with a revenue of 807.31 USD Billion in the year 2024.
- Novel Oral Anticoagulants (NOAC) is the Fastest growing segment in India Anticoagulation Therapy Market to 2032 with a Growth rate of 12.86 % in forecast period 2025-2032.
-
India Anticoagulation Therapy Market to 2032, By Drug Type
- Apixaban is the largest segment in India Anticoagulation Therapy Market to 2032 with a revenue of 579.08 USD Billion in the year 2024.
- Apixaban is the Fastest growing segment in India Anticoagulation Therapy Market to 2032 with a Growth rate of 13.46 % in forecast period 2025-2032.
-
India Anticoagulation Therapy Market to 2032, By End User
- Hospitals is the largest segment in India Anticoagulation Therapy Market to 2032 with a revenue of 959.23 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in India Anticoagulation Therapy Market to 2032 with a Growth rate of 12.75 % in forecast period 2025-2032.
-
India Anticoagulation Therapy Market to 2032, By Distribution Channel
- Hospital Pharmacies is the largest segment in India Anticoagulation Therapy Market to 2032 with a revenue of 1,134.24 USD Billion in the year 2024.
- Hospital Pharmacies is the Fastest growing segment in India Anticoagulation Therapy Market to 2032 with a Growth rate of 12.64 % in forecast period 2025-2032.
-
India Anticoagulation Therapy Market to 2032, By Treatment
- Deep Vein Thrombosis (DVT) is the largest segment in India Anticoagulation Therapy Market to 2032 with a revenue of 738.00 USD Billion in the year 2024.
- Deep Vein Thrombosis (DVT) is the Fastest growing segment in India Anticoagulation Therapy Market to 2032 with a Growth rate of 13.10 % in forecast period 2025-2032.
India Anticoagulation Therapy Market Company Share Analysis
India Anticoagulation Therapy Market Geographical Sales Distribution, 2018-2032 USD Billion
India Anticoagulation Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The India Anticoagulation Therapy Market is segmented based on Segmentation Route of Administration,Therapeutic Area,Procedure,Type,Therapeutic Class,Drug Type,End User,Distribution Channel,Treatment.
India Anticoagulation Therapy Market was valued at USD 1,719.81(Revenue in USD Billion) in 2022.
India Anticoagulation Therapy Market is projected to grow at a CAGR of 11.88% during the forecast period of 2024 to 2032.
The Generics segment is expected to dominate the India Anticoagulation Therapy Market, holding a largest market share of 1,135.39 USD Billion in 2024
India Anticoagulation Therapy Market Scope
India Anticoagulation Therapy Market Segmentation & Scope
Route of Administration
- Injectable
- Oral
Therapeutic Area
- Others
- CNS
- Respiratory
- Nephrology
- Oncology
- Cardiovascular Diseases
Procedure
- Heart Valve Replacement
- Kidney Dialysis
- Post-Surgical Procedures
- Pre-Surgical Procedures
Type
- Branded
- Generics
Therapeutic Class
- Others
- Vitamin K Antagonists
- Heparin
- Novel Oral Anticoagulants (NOAC)
Drug Type
- Delteparin
- Betrixaban
- Edoxaban
- Others
- Bivalirudin
- Dabigatran
- Enoxaparin
- Rivaroxaban
- Apixaban
End User
- Others
- Ambulatory Surgical Centers
- Homecare
- Clinics
- Hospitals
Distribution Channel
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
Treatment
- Others
- Stroke
- Arterial Thromboembolism(AT)
- Pulmonary Embolism(PE)
- Deep Vein Thrombosis (DVT)
Frequently Asked Questions
The India Anticoagulation Therapy Market is segmented based on Segmentation Route of Administration,Therapeutic Area,Procedure,Type,Therapeutic Class,Drug Type,End User,Distribution Channel,Treatment.
India Anticoagulation Therapy Market was valued at USD 1,719.81(Revenue in USD Billion) in 2022.
India Anticoagulation Therapy Market is projected to grow at a CAGR of 11.88% during the forecast period of 2024 to 2032.
The estimated market value of the India Anticoagulation Therapy Market for final year is USD 3,456.64 (USD Billion).
India Anticoagulation Therapy Market Company Profiling
Frequently Asked Questions
The India Anticoagulation Therapy Market is segmented based on Segmentation Route of Administration,Therapeutic Area,Procedure,Type,Therapeutic Class,Drug Type,End User,Distribution Channel,Treatment.
India Anticoagulation Therapy Market was valued at USD 1,719.81(Revenue in USD Billion) in 2022.
India Anticoagulation Therapy Market is projected to grow at a CAGR of 11.88% during the forecast period of 2024 to 2032.
The estimated market value of the India Anticoagulation Therapy Market for final year is USD 3,456.64 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.